New guideline urges ditching opioids for painful diabetic neuropathy

Neurology experts reviewed the latest evidence to offer new recommendations for management of painful neuropathy in diabetes patients.

4:00 PM

Author | Haley Otman

Needles in woman's hand and fire shooting from hands expressing pain. Bottle of pills floating.
Jacob Dwyer, Michigan Medicine.

The most common prescription taken for painful nerve damage in diabetes is likely dangerous, experts say.

Despite this risk, and a lack of evidence that opioids stop pain associated with diabetic neuropathy over the long term, data from a recent nationally representative study from University of Michigan Health shows they are the most-prescribed treatment for this painful condition.

A new diabetic polyneuropathy practice guideline from the American Academy of Neurology encourages providers to select better options, says Brian Callaghan, M.D., M.S., an associate professor of neurology at U-M who led its creation. Not only do opioids come with risks, but there is also no good evidence that they are effective in the long term.

SEE ALSO: Diabetes 101 video Q&A

Instead, the guideline recommends offering one of four classes of oral medications with strong evidence: tricyclic antidepressants; serotonin-norepinephrine reuptake inhibitors or SNRIs, another category of antidepressants; gabapentinoids, non-opioid analgesics commonly prescribed for chronic pain; and sodium channel blockers, which the guideline team's meta-analysis determined to be effective for neuropathic pain.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"We found that the effects of medications within a class were very similar to other medications within the same class," Callaghan said. "That allows clinicians to consider patient-specific factors like comorbidities, cost, patient preferences and potential adverse effects when selecting the specific medication to prescribe."

When a drug hasn't helped after three months, it's time to try another, according to the new guideline."However, managing expectations is also important," Callaghan said. "Our second recommendation urges the provider to be frank with patients that the goal is to reduce their pain. It may not be possible to completely resolve the symptoms."

Better detection needed for peripheral neuropathy

While more than 15% of people with diabetes experience peripheral neuropathy that's painful, there are still too many people who might never discuss it with their doctor, and thus not get any treatment for it, the authors write.

SEE ALSO: Neuropathy Study Finds Promise in Healthy Fats

"An important part of the guideline addresses this conversation that providers must have with their patients," Callaghan said. "It's important to ask people with diabetes about the presence of painful neuropathy, since we do have options to improve quality of life for these patients."

Exploring other pain management interventions for diabetic neuropathy

When a patient is interested in trying a nontraditional approach, the guideline offers recommendations for topical and nonpharmacologic options with the best evidence, like the topical treatment capsaicin, an exercise routine, and participation in cognitive behavioral therapy. On the other hand, it discourages those nontraditional options that have not been shown to be more effective than a placebo, including other oral medications and nutmeg extract.

In addition, the publication urges providers to address any mood and sleep disorders in their patients. Treating those common issues in this patient population can help with people's perception of their pain and quality of life, Callaghan said.

The results held true across all age groups and sexes.

To create the new guideline, a national team of clinicians, patient advocates and others with expertise in neuropathy and guideline methodology reviewed data from more than 100 randomized controlled trials over the past 20-plus years. Also published in Neurology, the medical journal of the American Academy of Neurology, it updates the previous guideline from 2011.

Paper cited: "Oral and topical treatment of painful diabetic polyneuropathy practice guideline update summary," Neurology.

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts

More Articles About: Rounds Diabetes Neuropathy & Peripheral Nerve Disorders chronic pain Medication Guidelines Sleep Disorders Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories cells floating pink purple green
Health Lab
Scientists develop new model for understanding sudden death in epilepsy
Researchers at the University of Michigan have developed a model for studying one type of familial epilepsy, opening the door to understanding—and eventually targeting—the mechanisms that lead to the disorder and its associated fatalities.
cars jammed on highway
Health Lab
Nearly one-fifth of older adults travel 50-plus miles to see a neurologist
A Michigan Medicine study finds older Americans with complex neurologic conditions travel may travel great distances for care, many of whom live in rural areas or regions with a limited number of specialists.
Health Lab
Chronic pain patients who take opioids need better care and coverage
People with chronic pain who take opioids have trouble finding multimodal pain care; insurance and provider education changes are needed, experts say
glioma brain scan
Health Lab
Study finds improved survival for incurable brain tumor, providing ‘a crack in the armor’
A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
images on computer of scans
Health Lab
Diabetes linked to functional and structural brain changes through MRI
A Michigan Medicine study finds Diabetes linked to functional and structural brain changes through MRI.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Even as the Epidemic Shifts, We're Seeing Treatment Disparities
A conversation with Dr. Pooja Lagisetty on the shifting face of the opioid epidemic, disparities in care and how we can more effectively treat substance use disorder.